NFKB1 and neoplasm: Using immunocompetent mice, Alameda et al. showed that a moderate increase in CYLD expression levels reduced NF-kB activation, which favored the differentiation of tumor epidermal cells and inhibited its proliferation and decreased tumor angiogenesis [11].